Home / Resource Library / KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell LymphomaKTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma Results of a phase II clinical trial investigating CAR T therapy KTE-X19 for treatment of relapsed mantle cell lymphoma.